## CL: Colgate-Palmolive Company - XLP: Consumer Defensive

### Executive Summary

No thesis match: MRS_10 -0.7% below STRENGTH zone (3.0-6.0%); PEG 3.10 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($77.11)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Neutral (Bullish: 2, Bearish: 0)

**1. Colgate-Palmolive India receives ₹267.64 crore tax demand, plans appeal**
- Source: Storyboard18 | 20251226T110950 | Somewhat-Bearish | Relevance: 100%
- Colgate-Palmolive (India) has received a tax demand of ₹267.64 crore for the financial year 2021–22, which the company plans to appeal before the appellate tribunal. The demand primarily relates to inter-company pricing adjustments and expense disallowances, which the FMCG major stated would not materially impact its business. This development occurs amidst concerns from industry executives regarding tax certainty and dispute resolution mechanisms in India.

**2. AMI Asset Management Corp Has $41.42 Million Stock Position in Colgate-Palmolive Company $CL**
- Source: MarketBeat | 20251226T081904 | Neutral | Relevance: 100%
- AMI Asset Management Corp decreased its stake in Colgate-Palmolive Company by 3.6% in Q3, now holding 518,183 shares valued at approximately $41.42 million. This position constitutes 2.3% of AMI's portfolio. Despite several analyst price target cuts, Colgate-Palmolive maintains a "Moderate Buy" consensus rating with an average target of $88.81. The company recently exceeded EPS expectations but missed revenue forecasts, and declared a quarterly dividend of $0.52 per share.

**3. FMCG major Colgate-Palmolive to appeal ₹267 crore tax demand**
- Source: A2Z Taxcorp LLP | 20251227T124049 | Somewhat-Bearish | Relevance: 100%
- Colgate-Palmolive (India) Limited has announced its intention to appeal an income tax demand of ₹267.64 crore for the financial year 2021-22. The demand primarily stems from transfer pricing adjustments and disallowed expenses. Despite the demand, the company assures that there will be no impact on its financials, operations, or business activities, classifying it as a disputed tax matter rather than an immediate cash outflow.

**4. Pacer Advisors Inc. Increases Position in Colgate-Palmolive Company $CL**
- Source: MarketBeat | 20251226T120550 | Bullish | Relevance: 100%
- Pacer Advisors Inc. significantly increased its stake in Colgate-Palmolive Company (NYSE:CL) by over 3,000% during the third quarter, now owning 2.697 million shares valued at $215.6 million. Other institutional investors like Vanguard Group Inc., Norges Bank, and Invesco Ltd. also adjusted their positions in the consumer goods giant. Colgate-Palmolive reported mixed Q3 earnings, beating EPS estimates but missing revenue forecasts, and declared a quarterly dividend of $0.52 per share.

**5. Colgate-Palmolive Company $CL Shares Purchased by Canoe Financial LP**
- Source: MarketBeat | 20251226T094749 | Somewhat-Bullish | Relevance: 100%
- Canoe Financial LP increased its stake in Colgate-Palmolive Company (NYSE:CL) by 23.3% in the third quarter, bringing their total holdings to 99,646 shares valued at $7,966,000. Other institutional investors like Pacer Advisors Inc. and Secured Retirement Advisors LLC also significantly increased their positions in the company, indicating strong institutional confidence. Analysts currently rate Colgate-Palmolive as a "Moderate Buy" with an average price target of $88.81.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 1, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-18 | JP Morgan | $88 | $87 | +1% |
| 2025-12-11 | Argus Research | $0 | $0 | 0% |
| 2025-12-09 | RBC Capital | $88 | $0 | 0% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-18 | JP Morgan | main | Overweight |
| 2025-12-11 | Argus Research | down | Hold |
| 2025-12-09 | RBC Capital | up | Outperform |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 3 ($0.07M) |
| Sells | 7 ($0.28M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 37.8% |
| Smart Money | **BEARISH** |
| Net Flow | 0.0% |
| Buying/Selling | 4 / 5 |

**Top Holders:**
- Vanguard Group Inc: 10.3% (+0.2%)
- Blackrock Inc.: 8.6% (+0.5%)
- State Street Corpora: 6.0% (+0.2%)
- Price (T.Rowe) Assoc: 4.0% (-11.5%)
- Geode Capital Manage: 2.7% (+4.1%)

### Key Risks

1. Valuation stretched: PEG 3.1x requires aggressive growth execution.
2. Long-term trend broken: trading 6.7% below SMA200.
3. Market regime shift could impact momentum names disproportionately.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 3.10 signals overvaluation risk, limited margin of safety. Forward P/E 20.8x stretched relative to 5% growth. Quality metrics strong (ROE 294%, ROA 15%). Balance sheet: $1.1B free cash flow. Institutional flow bearish (5 selling vs 4 buying).

| Metric | Value |
|--------|-------|
| Market Cap | $64.4B |
| Beta | 0.29 |
| 52W Range | $74.55 - $100.18 |
| Short Interest | 1.9% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 3.10 |
| Forward P/E | 20.8 |
| Current P/E | 21.8 |
| YoY Growth | 5.0% |
| EPS Direction | STABLE |

### Technicals

MRS_10 weakening modestly (-0.9% over 5 days). Below STRENGTH zone by 3.7pp (needs >3.0% for momentum thesis). Below SMA200 (0.93x), long-term trend not supportive. RSI neutral at 54. OFD pattern: -SUL (Resistance).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | -0.71% (CS: 55) | Neutral |
| RSI_14 | 54.4 | Neutral |
| MACD Histogram | 0.20 | Bullish |
| vs SMA20 | 1.014x | Above |
| vs SMA50 | 1.017x | Above |
| vs SMA200 | 0.933x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $79.73
- **Stop Loss:** $77.11 (3.3% risk)
- **Target:** $82.35 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 209
- **Position Value:** $16,663.57
- **Portfolio %:** 16.66%
- **Risk Dollars:** $550.00
- **Risk Per Trade:** 0.55%
- **Modifiers:** L1 110% | L2 50% | Combined 0.55x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.10x |
| L2 Sector | AVOID (Zone C) | 0.50x |

*NORMAL regime with selective risk appetite amid holiday trading. VIX at extreme lows (13.6) signals complacency while positive yield curve (+59bps) and stable economic data support continuation. Focus on quality names with AI/infrastructure exposure while monitoring January volatility reset.*

### Earnings

**Next:** 2026-01-30 (Est: $0.91)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.89 | $0.91 | +2.4% |
| 2025Q2 | $0.89 | $0.92 | +2.8% |
| 2025Q1 | $0.86 | $0.91 | +6.1% |
| 2024Q4 | $0.89 | $0.91 | +2.3% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*